Image via Digital Health
Last updated
Holland & Barrett: Partnership
Holland & Barrett established a partnership with Phlo in the digital health space
Source: Digital Health
The leadership read
Alliances like this can broaden the sector commercial leadership bench strength.
“considerable potential to build on that beyond Singapore and Hong Kong over time”
“Launching first in Singapore allows both organisations to introduce the Holland & Barrett proposition in a market that is receptive to science-led products, while also providing valuable insights that can support future expansion across the region.”
Market context: Backdrop: a 107.9 (Hot) Talent Market Index (up 2.4 on the month) with EMEA activity easing (-8.7pts).
Holland & Barrett: 1 signal in the last 90 days; 0.1% of MitchelLake's EMEA signal flow.
More signals across EMEA
Partnership · EMEA
Safran →Safran Electronics & Defense signed letter of intent to join Bliksem EXO consortium for exo-atmospheric interceptor development. Safran to provide kill vehicle seeker and guidance, navigation and control systems.
Partnership · EMEA
Arcadis →Arcadis appointed to Transport for London's Professional Services Framework 3, expanding its public sector infrastructure advisory footprint in the UK.
Partnership · EMEA
Revolut →Revolut selected as one of 36 payment service providers to participate in ECB's 12-month digital euro pilot, starting H2 2027. Will test person-to-person and person-to-business transaction capabilities with beta digital euro.
Partnership · EMEA
Adyen →Adyen selected by European Central Bank to participate in digital euro pilot involving 36 payment firms, focusing on cross-border payments within Europe as alternative to US dollar-backed stablecoins.
Partnership · EMEA
BVNK →BVNK secured LemFi as major enterprise client to power stablecoin settlement for 2m+ users across remittance corridors
Partnership · EMEA
Alnylam Pharmaceuticals →Alnylam expanded GENESIS Pharma distribution deal into northern Europe and deepened AI collaboration with Komodo Health following rival ATTR-CM therapy failure, strengthening competitive position
Intelligence powered by Autonodal ↗